Pharma Industry
Pharma Industry 03/09/2008
Value of direct-to-consumer drug advertising oversold, study finds
Despite the billions spent on bringing drug marketing campaigns straight into patients' living rooms, such strategies have a modest effect at best—and in some cases, no effect at all.
Pharma Industry 03/09/2008
Gilead may shoot past big firms' buyout hunts
Soon, Gilead Sciences of Foster City may be the last one still standing as an independent big-cap biotech company that has not been swallowed by a bigger pharma fish.
Pharma Industry 01/09/2008
Abbott Fund to build first pediatric HIV/AIDS clinic in Tanzania
Joint effort with Baylor International Pediatric AIDS Initiative will improve access to health care for children with HIV/AIDS.
Pharma Industry 01/09/2008
Pharma to boycott UK?
From being one of the least regulated markets in Europe, the new agreement will move the UK to one of the most heavily regulated, Andrew Monro, a partner at consultancy KPMG in London, points out.
Pharma Industry 01/09/2008
UK strong arms industry over drug pricing
The UK pharmaceutical and biotech industries are claiming success in their negotiations with government over drug prices, although the deal is less than propitious.
Pharma Industry 29/08/2008
Indian pharma exports “to grow 18.5% a year”
Pharmaceutical exports from India are set to increase by an average 18.5% a year to 2012, driven by multi-billion dollar patent expirations and growth in the global generics market, according to a new report.
Pharma Industry 26/08/2008
Is NICE looking for more influence in new drug pricing plan?
A controversial new role for the UK health watchdog in the forthcoming overhaul of drugs pricing.
Pharma Industry 25/08/2008
Russia to enter top 10 pharma markets by end of year
Sales of medicines in Russia are expected to grow over 30% in dollar terms in 2008, which will push it into the top 10 pharmaceutical markets in the world, notes a new study.
Pharma Industry 25/08/2008
HIV/AIDS groups express concern about potential for new antiretroviral advertising to 'scare off' patients
The Wall Street Journal on Monday examined a new trend for drugmakers marketing HIV/AIDS treatments to release ads that "take aim at rival HIV drugs, hinting at side effects and other drawbacks."
Pharma Industry 22/08/2008
GSK to provide public with more information
GlaxoSmithKline said Thursday it will, beginning in February 2009, proactively report educational and charitable grants provided to health-related organizations in the United States.
Pharma Industry 22/08/2008
Health chief attacks drug giants over huge profits
The drugs industry is overpricing vital new medicines to boost its profits.
Pharma Industry 18/08/2008
ProPublica examines U.S. investigation into pharmaceutical company Ranbaxy over antiretrovirals used in PEPFAR, other drugs
Ranbaxy under a U.S. government contract was paid to provide low-cost antiretroviral drugs under PEPFAR, and investigators have said that some of the drugs were substandard, impotent or unstable.
Pharma Industry 30/07/2008
Abbott to settle lawsuit over AIDS drug pricing
On the eve of a trial, Abbott is agreeing to settle the case for between $10 million to $27.5 million, rather than battle charges that it tried to create a monopoly for Kaletra.
Pharma Industry 28/07/2008
Ambrilia provides update on PPL-100 partnership with Merck & Co, Inc.
The HIV protease inhibitor PPL-100, also known as MK-8122, has been placed on a development hold pending outcome of additional basic science efforts to evaluate other PL-100 prodrugs and formulations options.
Pharma Industry 27/07/2008
Big Pharma self-medicates in a bid to lift ailing returns
Tough times are forcing firms to diversify, says Richard Wachman.
Pharma Industry 24/07/2008
Witty says GSK must change as strategic shift is outlined
GlaxoSmithKline has posted an unspectacular set of financial results for the second quarter but this has been overshadowed by the firm setting out a major strategic shift to focus less on looking for blockbusters and build up its vaccine and consumer health businesses instead.
Pharma Industry 23/07/2008
Roche/Amgen case could signal shift in courts regarding compulsory licenses
It is now only a matter of time until a permanent injunction is refused and a compulsory license is handed down by an American judge in a case involving pharmaceutical companies.
Pharma Industry 23/07/2008
FDA chief counsel soon on GSK payroll
In a move that is likely to make industry watchdogs wag their tales, Daniel Troy, formerly chief counsel at FDA from 2001 to 2004, has just signed on to be a senior vice president and general counsel at GlaxoSmithKline.
Pharma Industry 21/07/2008
Roche offers to buy out Genentech
Swiss drugmaker Roche Holding offered to acquire all outstanding shares in its U.S. partner Genentech Inc for $43.7 billion in cash to reinforce its position in cancer medicines.
Pharma Industry 21/07/2008
New HIV treatments slash into sales of Trimeris' Fuzeon
Global sales of Trimeris' HIV drug, Fuzeon, dropped 38 percent in the second quarter.
More...
